title: [Mechanisms of action and clinical effectiveness of the newly approved anti-cancer drug bendamustine].
authors: furuyu@jiichi.ac.jp
authors: Yusuke
authors: Y
authors: Furukawa
authors: Nobuya
authors: N
authors: Hiraoka
authors: Taeko
authors: T
authors: Wada
authors: Jiro
authors: J
authors: Kikuchi
authors: Yasuhiko
authors: Y
authors: Kano
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D002986:Clinical Trials as Topic; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride